IVCC is the only Product Development Partnership (PDP) working in vector control. IVCC was established in 2005, through a $50 million grant to the Liverpool School of Tropical Medicine (LSTM) from the Bill & Melinda Gates Foundation, and is a registered charity in the UK. We work with stakeholders to facilitate the development of novel and improved public health insecticides and formulations to combat the rapidly growing problem of insecticide resistance. We bring together partners from industry, the public sector and academia to create new solutions to prevent disease transmission. By focusing resources and targeting practical scientific solutions we accelerate the process from innovation to impact. IVCC’s mission is to facilitate innovative approaches to preventing vector-borne diseases by directly targeting the vector which transmits the disease. Where vector control has been consistently applied in the past, the results have been impressive, with 78% of averted clinical cases of malaria being attributed to bed nets and Indoor Residual Spraying (IRS). However, the success of vector control tools is threatened by the development and spread of insecticide resistance.IVCC is working with a range of partners to facilitate the development of novel and improved public health insecticides, formulations and products to address these challenges. An integral part of preventing insect-borne diseases is ensuring that vector control products are integrated into country level control programmes and have an equitable impact amongst all countries and people that need them. IVCC’s Global Access Strategy is driven by the need for products emerging from the Research and Development Portfolio to be available, affordable, acceptable and adopted. Additionally, as new anti-malaria insecticides become available it will be important to manage the use of these new products in order to prevent a new round of insecticide resistance from developing.
